Medtronic gets U.S. antitrust OK to buy Covidien with divestiture | Business Information & News | Westlaw

Medtronic gets U.S. antitrust OK to buy Covidien with divestiture | Business Information & News | Westlaw

View on Westlaw or start a FREE TRIAL today, Medtronic gets U.S. antitrust OK to buy Covidien with divestiture, Business Information & News
11/26/14 REUTERS 21:08:02
REUTERS
Copyright © 2014 Thomson Reuters
November 26, 2014
Medtronic gets U.S. antitrust OK to buy Covidien with divestiture
Diane Bartz
WASHINGTON (Reuters) - U.S. antitrust regulators on Wednesday approved a pair of major deals in the medical field, including Medtronic's purchase of Covidien, which will allow it to take advantage of tax breaks in Ireland.
The Federal Trade Commission...
---- Index References ----
Company: NOVARTIS INC; JOHNSON AND JOHNSON; SPECTRANETICS CORP (THE); GLAXOSMITHKLINE PLC; MEDTRONIC INC; COVIDIEN
News Subject: (Major Corporations (1MA93))
Industry: (Cardiovascular Catheters (1CA95); Healthcare Practice Specialties (1HE49); Pharmaceuticals & Biotechnology (1PH13); Healthcare (1HE06); Internal Medicine (1IN54); Cardiovascular Devices (1CA41); Cardiology (1CA75); Pharmaceuticals (1PH33); Medical Devices (1ME31))
Region: (Switzerland (1SW77); Western Europe (1WE41); Ireland (1IR50); Eurozone Countries (1EU86); Central Europe (1CE50); Europe (1EU83))
Language: EN
Keywords: securities; ma; antitrust; health (MCC:f); (N2:US); (N2:AMERS); (N2:USA); (MCCL:OVR); (MCCL:OEC)
Word Count: 376
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.